|
For normal heart rhythm, there must be an orderly propagation of electrical impulses throughout the myocardium. When this orderly progression is disrupted for any reason, potentially lethal cardiac arrhythmias can result. In the United States alone, 9 million people have heart failure or structural heart disease, both of which can result in electrophysiological changes that make the heart more vulnerable to electrical instability and resultant cardiac arrhythmias. Given recent advances in the field, experts agree that physicians' knowledge and treatment practices can differ from current best practice. Symposium organizers have noted this knowledge/treatment gap through a variety of measures and have created this educational event as a means of meeting the unmet educational need of the target audience.
This symposium will focus on recent findings regarding common problems facing physicians who treat patients with cardiac arrhythmias. The faculty will discuss evaluation and treatment of patients with supraventricular and ventricular arrhythmias, including pharmacologic therapies and the use of implantable cardioverter defibrillators and biventricular pacing. The molecular and cellular basis of conduction disturbances will also be discussed with the goal of providing insights into the fundamental mechanisms of cardiac arrhythmias and the identification of appropriate targets for antiarrhythmic therapy.
Interactive case presentations will provide clinicians and faculty the opportunity to discuss specific treatment challenges and to learn methods that will be useful in their practices.
Learning Objectives
At the conclusion of this symposium, participants should be able to -
-
Summarize recent findings regarding treatment of atrial fibrillation inclusive of various adult populations.
-
Describe common troubleshooting of single- and dual-chambered implantable cardioverter defibrillators.
-
Cite the mechanisms of action of antiarrhythmic medications for their safe and effective use.
-
Summarize available therapies for the prevention of stroke in atrial fibrillation. - Recognize ECG findings of tachycardias
Target Audience Cardiologists, Cardiologists
with an interest in electrophysiology, Cardiac Electrophysiologists, Internists
with an interest in cardiology, THI cardiology fellows, SLEH Cath lab
technicians, Internal Medicine, Family Practice, and General Practitioners.
Preliminary Program Schedule Saturday February 16, 2013
7:30 a.m. Registration and Continental Breakfast
8:00 a.m. Welcome by Ali Massumi, MD
Session I
8:15 – 8:45 a.m.
Guideline Update and Current Choices in Atrial Fibrillation
Eric Prystowsky, MD
8:45 - 9:15 a.m.
History and Current Status of Atrial Fibrillation Ablation
Abdi Rasekh, MD
9:15 – 9:45 a.m.
Stroke Prevention and Atrial Fibrillation: Drugs and Devices
Mehdi Razavi, MD
9:45 – 10:00 a.m. Panel Discussion & Q&A
10:00 – 10:15 a.m. Break
Session II
10:15 – 10:45 a.m.
Advances in Non-Pharmacological Management of Heart Failure
Nilesh Mathuria, MD
10:45 – 11:15 a.m.
ICD Troubleshooting for the Non-EP Physician
Mohammad Saeed, MD
11:15 – 11:45 a.m.
Arrhythmic Implications of Percutaneous Aortic Valve Replacements
Ali Massumi, MD
11:45 – 12:00 noon Panel Discussion & Q&A
12:00 – 1:00 p.m. Lunch
Session III
1:00– 1:30 p.m.
EP Jeopardy
J. Michael Bensler, MD
1:30 – 2:00 p.m.
ECG Recognition of SVTs
C. Thomas Peter, MD
2:00 – 2:45 p.m.
Case Presentations
THI Electrophysiology Fellows
2:45 – 3:00 p.m.
Closing Remarks
Ali Massumi, MD
3:00 p.m. Adjourn
See the brochure for more details.
| 
